BPH - Benign Prostatic Enlargement - Results from #2220

REVIEW UroToday

PDE5 inhibitors blunt inflammation in human BPH: A potential mechanism of action for PDE5 inhibitors in LUTS - Abstract September 20, 2013

Multi-center randomized controlled blinded study of the prostatic urethral lift for the treatment of LUTS associated with prostate enlargement due to BPH: The L.I.F.T. Study - Abstract September 19, 2013

The effects of chlormadinone acetate on lower urinary tract symptoms and erectile functions of patients with benign prostatic hyperplasia: A prospective multicenter clinical study - Abstract September 18, 2013

Enablers and barriers affecting medication-taking behaviour in aging men with benign prostatic hyperplasia - Abstract September 18, 2013

Dutasteride for the treatment of benign prostatic hyperplasia - Abstract September 16, 2013

Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: A multicenter randomized trial - Abstract September 13, 2013

Urodynamics and safety of the β3-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction - Abstract September 12, 2013

The efficacy and safety of combined therapy with alpha-blockers and anticholinergics for men with benign prostatic hyperplasia: A meta-analysis - Abstract September 12, 2013

Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100-149 mL benign prostatic hyperplasia - Abstract September 10, 2013

Follow-up observation of photoselective vaporization of prostate for treatment of benign prostatic hyperplasia within five years - Abstract September 9, 2013

Analysis of operative complications of photoselective vaporization of prostate (120 W) for treatment of benign prostatic hyperplasia - Abstract September 6, 2013

The recent clinical efficacy study of photoselective vaporization of prostate (120 W) for treatment of large gland benign prostatic hyperplasia - Abstract September 5, 2013

The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia - Abstract September 4, 2013

Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: Results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study - Abstract September 4, 2013

A rare but serious complication of GreenLight HPS photoselective vaporization of the prostate: Prostatic capsular perforation with bilateral thigh urinomas and osteitis pubis - Abstract September 3, 2013

Laser prostatectomy: Holmium laser enucleation and photoselective laser vaporization of the prostate - Abstract August 30, 2013

Transurethral plasmakinetic enucleation of prostate and suprapubic small cut in the treatment of high risk and senior patient with benign prostatic hyperplasia and bladder stones - Abstract August 30, 2013

Evaluation and validation of the Core Lower Urinary Tract Symptom Score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: Effects of the α1-adrenoreceptor antagonist silodosin - Abstract August 28, 2013

Advances in the design and discovery of drugs for the treatment of prostatic hyperplasia - Abstract August 28, 2013

Mirabegron for male lower urinary tract symptoms - Abstract August 27, 2013

Page 112 of 140